Richard S Lindahl - Net Worth and Insider Trading

Richard S Lindahl Net Worth

The estimated net worth of Richard S Lindahl is at least $531,591 dollars as of 2024-12-01. Richard S Lindahl is the EVP, CFO of Emergent BioSolutions Inc and owns about 39,919 shares of Emergent BioSolutions Inc (EBS) stock worth over $403,980. Richard S Lindahl is also the Treasurer of Sprint Corp and owns about 14,804 shares of Sprint Corp (S) stock worth over $127,610. Details can be seen in Richard S Lindahl's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard S Lindahl has not made any transactions after 2021-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard S Lindahl

To

Richard S Lindahl Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard S Lindahl owns 3 companies in total, including Emergent BioSolutions Inc (EBS) , CEB Inc (CEB) , and Compass Therapeutics Inc (CMPX) .

Click here to see the complete history of Richard S Lindahl’s form 4 insider trades.

Insider Ownership Summary of Richard S Lindahl

Ticker Comapny Transaction Date Type of Owner
EBS Emergent BioSolutions Inc 2021-11-15 EVP & Chief Financial Officer
CEB CEB Inc 2017-04-05 Chief Financial Officer
CMPX Compass Therapeutics Inc 2023-04-21 director

Richard S Lindahl Latest Holdings Summary

Richard S Lindahl currently owns a total of 2 stocks. Among these stocks, Richard S Lindahl owns 39,919 shares of Emergent BioSolutions Inc (EBS) as of November 15, 2021, with a value of $403,980 and a weighting of 75.99%. Richard S Lindahl also owns 14,804 shares of Sprint Corp (S) as of August 19, 2005, with a value of $127,610 and a weighting of 24.01%.

Latest Holdings of Richard S Lindahl

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EBS Emergent BioSolutions Inc 2021-11-15 39,919 10.12 403,980
S Sprint Corp 2005-08-19 14,804 8.62 127,610

Holding Weightings of Richard S Lindahl


Richard S Lindahl Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard S Lindahl has made a total of 1 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Emergent BioSolutions Inc is the acquisition of 3,000 shares on November 15, 2021, which cost Richard S Lindahl around $112,380.

According to the SEC Form 4 filings, Richard S Lindahl has made a total of 0 transactions in Sprint Corp (S) over the past 5 years. The most-recent trade in Sprint Corp is the sale of 49,374 shares on August 19, 2005, which brought Richard S Lindahl around $1 Million.

Insider Trading History of Richard S Lindahl

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard S Lindahl Trading Performance

GuruFocus tracks the stock performance after each of Richard S Lindahl's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard S Lindahl is 18.25%. GuruFocus also compares Richard S Lindahl's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard S Lindahl within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard S Lindahl's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard S Lindahl

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.55 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.97 LIMIT LIMIT LIMIT LIMIT LIMIT

Richard S Lindahl Ownership Network

Ownership Network List of Richard S Lindahl

No Data

Ownership Network Relation of Richard S Lindahl

Insider Network Chart

Richard S Lindahl Owned Company Details

What does Emergent BioSolutions Inc do?

Who are the key executives at Emergent BioSolutions Inc?

Richard S Lindahl is the EVP & Chief Financial Officer of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .

Emergent BioSolutions Inc (EBS) Insider Trades Summary

Over the past 18 months, Richard S Lindahl made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 16,449 shares made by Kathryn C Zoon , a net sale of 25,000 shares made by Donald W Degolyer , and a net sale of 14,287 shares made by Marvin L White .

In summary, during the past 3 months, insiders sold 39,287 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 39,287 shares. During the past 18 months, 55,736 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 55,736 shares.

Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Emergent BioSolutions Inc Insider Transactions

No Available Data

Richard S Lindahl Mailing Address

Above is the net worth, insider trading, and ownership report for Richard S Lindahl. You might contact Richard S Lindahl via mailing address: Nextel, 2001 Edmund Halley Dr, Reston Va 20191.

Discussions on Richard S Lindahl

No discussions yet.